Administration of erythropoiesis ‐stimulating agents in patients undergoing haemodialysis: a time and motion study

ConclusionSwitching from a short‐acting to a long‐acting ESA in HD units leads to a significant reduction in time costs of health professionals in preparation and administration of ESAs by up to 80%.Practical application: This time and motion study has added further evidence on reduction of human effort by taking advantages of new research development, such as the long acting ESAs.

Source: Journal of Renal Care - September 1, 2017 Category: Urology & Nephrology Authors: David W. Johnson, Bruce Cleland, Josette Eris, Tom Rafferty, Kamal Sud, Josephine S. Chow Tags: Original Research Source Type: research